98 related articles for article (PubMed ID: 28456593)
1. The role of miR-372 in ovarian carcinoma cell proliferation.
Guan X; Zong ZH; Chen S; Sang XB; Wu DD; Wang LL; Liu Y; Zhao Y
Gene; 2017 Aug; 624():14-20. PubMed ID: 28456593
[TBL] [Abstract][Full Text] [Related]
2. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer.
Lin Z; Zhao J; Wang X; Zhu X; Gong L
Oncol Rep; 2016 Oct; 36(4):2101-7. PubMed ID: 27513319
[TBL] [Abstract][Full Text] [Related]
4. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
Feng S; Sun H; Zhu W
Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
[TBL] [Abstract][Full Text] [Related]
5. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
Wang TT; Chen ZZ; Xie P; Zhang WJ; Du MY; Liu YT; Zhu HY; Guo YS
Eur J Pharmacol; 2019 Aug; 856():172352. PubMed ID: 31004603
[TBL] [Abstract][Full Text] [Related]
9. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
10. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
[TBL] [Abstract][Full Text] [Related]
11. miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.
Shi C; Zhang Z
Tumour Biol; 2016 Apr; 37(4):5437-43. PubMed ID: 26563371
[TBL] [Abstract][Full Text] [Related]
12. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
13. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
Wu H; Xiao Z; Wang K; Liu W; Hao Q
Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
[TBL] [Abstract][Full Text] [Related]
15. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
[TBL] [Abstract][Full Text] [Related]
16. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.
Liao Y; Deng Y; Liu J; Ye Z; You Z; Yao S; He S
Gynecol Oncol; 2016 Dec; 143(3):655-663. PubMed ID: 27726922
[TBL] [Abstract][Full Text] [Related]
17. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.
Yang X; Yu J; Yin J; Xiang Q; Tang H; Lei X
Pharmazie; 2012 Jul; 67(7):645-51. PubMed ID: 22888524
[TBL] [Abstract][Full Text] [Related]
18. MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma.
Ma F; Zhang M; Gong W; Weng M; Quan Z
PLoS One; 2015; 10(5):e0126499. PubMed ID: 25962180
[TBL] [Abstract][Full Text] [Related]
19. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
20. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells].
Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ
Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]